CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...